+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The Lugano statements on controlled clinical trials

Journal of International Medical Research 15(1): 2-22
The Lugano statements on controlled clinical trials
During a consensus conference in Lugano, Switzerland, 175 statements on controlled clinical trials were drafted by 47 representatives from academia, governmental registration agencies and industry in nine countries. Their opinion on these statements was similar to that of 47 'matched pairs' who did not attend the conference. Thus, the opinion of participants and non-participants appears to reflect the general opinion of those currently involved in designing, conducting and analysing controlled clinical trials. The Lugano statements give answers to the following questions: Is the controlled clinical trial in a crisis? What is the motivation to perform controlled clinical trials? Is it possible for a physician participating in a controlled clinical trial to act in the patient's best interest? Is it possible to obtain truly informed consent in a controlled clinical trial? When is it ethical to withhold active treatment in a controlled clinical trial? What are the controversial issues in the design of a good controlled clinical trial? Is there a double standard with respect to efficacy and adverse drug reactions in controlled clinical trials? What are the alternatives to controlled clinical trials and when should they be performed? How can sponsor bias be minimized? How should an ethics committee decide whether a controlled clinical trial is ethical? Should registration agencies become directly involved in the planning and conduct of controlled clinical trials? Do the declarations of Tokyo and Helsinki facilitate the conduct of ethically valid controlled clinical trials? Is it possible to create an international standard for the conduct and regulation of controlled clinical trials? Why do messages from controlled clinical trials filter into medicine so slowly? Is it possible to bridge the gap between controlled clinical trials and clinical reality? What are the costs of doing and not doing controlled clinical trials? When should drug companies decide to start a trial programme with a specific compound? Is there public hostility against controlled clinical trials? If so, how can it be reduced? The respondents almost unanimously felt that controlled clinical trials are a must: the public must be told that progress in medicine depends on controlled clinical trials, that patients often benefit from participating in them and that the alternative, practising in the face of constant uncertainty, is worse than the possible disadvantages related to the conduct of the trial.

(PDF 0-2 workdays service: $29.90)

Accession: 006712341

PMID: 3817279

Related references

CONSORT and QUOROM statements revisited: standards of reporting of randomized controlled trials in general surgery. Annals of Surgery 248(6): 1106-7; Discussion 1107-8, 2009

What makes placebo-controlled trials unethical? Therapeutic beneficence and patient recruitment in randomized controlled clinical trials. American Journal of Bioethics 2(2): 35-36, 2002

Vasectomy techniques for male sterilization: systematic Cochrane review of randomized controlled trials and controlled clinical trials. Human Reproduction 19(11): 2431-2438, 2004

Searching for randomised controlled trials and clinical controlled trials in Thai online bibliographical biomedical databases. Health Information and Libraries Journal 28(1): 68-76, 2011

Likely country of origin in publications on randomised controlled trials and controlled clinical trials during the last 60 years. Trials 8(): 7-7, 2007

ISMICS Consensus Conference and Statements of Randomized Controlled Trials of Off-Pump Versus Conventional Coronary Artery Bypass Surgery. Innovations 10(4): 219-229, 2016

Clinical trials in India: issues with adherence to CONSORT statements. Journal of Clinical Epidemiology 64(8): 925-926, 2011

Controlled clinical trials: yes or no? Tasks and limits of controlled clinical trials in surgery. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(4): 281-288, 1981

Endorsement of the CONSORT and STROBE statements for plastic surgical clinical trials. Annals of Plastic Surgery 66(3): 321-321, 2011

Is the incidence of postoperative anastomotic leakage different between laparoscopic and open total mesorectal excision in patients with rectal cancer? A meta-analysis based on randomized controlled trials and controlled clinical trials. Journal of Cancer Research and Therapeutics 10 Suppl(): 272-275, 2015